4-INDAZOLYLAMINO-2-(2-(INDOL-3-YL)ETHYL)AMINOPYRIMIDINES USEFUL FOR THE TREATMENT OF CANCER
                        
                            
                                申请人:NOVIGA RESEARCH AB
                            
                            
                                公开号:US20150225374A1
                            
                            
                                公开(公告)日:2015-08-13
                            
                            The invention provides novel indazole-substituted diaminopyrimidines of formula I, to methods of preparing such compounds, to pharmaceutical compositions containing such compounds, and to methods for using such compounds in treatment of diseases including cancer; wherein R
1
-R
8
are as defined in the specification.